Overexpression of NDR1 in mice decreases AMPK and the downstream Acetyl-CoA-carboxylase phosphorylation, which leads to enhanced de novo lipogenesis and increased incidence of non-alcoholic fatty liver diseases (NAFLD). This evidence concerns the gene STK38 and metabolic dysfunction-associated steatotic liver disease.